FDA Committee Recommends Approval of Descovy for HIV PrEP Indication
Descovy was initially approved in April 2016 for the treatment of HIV in adults and pediatric patients weighing at least 35 kg in combination with other ...
ZAHIV | South Africa Standard Time —
Wednesday, August 14, 2019
View web version